Canada markets open in 7 hours 11 minutes

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.5900-0.0200 (-1.24%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 107.62M
Enterprise Value 24.55M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)240.55
Price/Book (mrq)1.19
Enterprise Value/Revenue 69.54
Enterprise Value/EBITDA -0.47

Trading Information

Stock Price History

Beta (5Y Monthly) 1.23
52-Week Change 3-7.56%
S&P500 52-Week Change 321.61%
52 Week High 32.7000
52 Week Low 31.0800
50-Day Moving Average 31.8393
200-Day Moving Average 31.6340

Share Statistics

Avg Vol (3 month) 3562.8k
Avg Vol (10 day) 3387.37k
Shares Outstanding 567.94M
Implied Shares Outstanding 667.94M
Float 860.12M
% Held by Insiders 12.62%
% Held by Institutions 161.82%
Shares Short (Mar 28, 2024) 4436.89k
Short Ratio (Mar 28, 2024) 40.62
Short % of Float (Mar 28, 2024) 40.91%
Short % of Shares Outstanding (Mar 28, 2024) 40.64%
Shares Short (prior month Feb 29, 2024) 4108.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 01, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:14
Last Split Date 3Jul 01, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-15,557.79%

Management Effectiveness

Return on Assets (ttm)-31.72%
Return on Equity (ttm)-62.31%

Income Statement

Revenue (ttm)353k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -54.33M
Net Income Avi to Common (ttm)-50.39M
Diluted EPS (ttm)-0.9400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)98.17M
Total Cash Per Share (mrq)1.45
Total Debt (mrq)15.1M
Total Debt/Equity (mrq)16.69%
Current Ratio (mrq)6.27
Book Value Per Share (mrq)1.43

Cash Flow Statement

Operating Cash Flow (ttm)-33.22M
Levered Free Cash Flow (ttm)-21.18M